National Centre for Clinical Research on Emerging Drugs
About
In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 1.5k papers, which have received a total of 76.8k indexed citations.
Scholars at this organization have produced 682 papers in Epidemiology, 572 papers in Infectious Diseases and 323 papers in Virology on the topics of Prevention and Treatment of HIV/AIDS Infection (433 papers), HIV Research and Treatment (320 papers) and HIV, Drug Use, Sexual Risk (306 papers). Their work is cited by papers focused on Epidemiology (31.9k citations), Infectious Diseases (25.9k citations) and Virology (15.6k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include John Kaldor, Matthew Law, David A. Cooper, Gregory J. Dore and Andrew E. Grulich
In The Last Decade
Explore institutions with similar magnitude of impact
Top fields impacted by scholars at Max Planck Institute for Heart and Lung Research Top countries impacted by scholars at Family Health International 360 Top countries scholars at Becton Dickinson (United States) are collaborate with authors working in Top fields impacted by scholars at Ecologie et Ecophysiologie Forestières Top fields scholars at Dana (United States) are working on Top countries scholars at Denver VA Medical Center are collaborate with authors working in Top fields scholars at Health and Human Development (2HD) Research Network are working on Top fields scholars at Baxter (United States) are working on